PDS Biotechnology Corp. Shares Close the Week 21.6% Lower - Weekly Wrap

The company saw its shares close the week 21.6% lower than last week, with trading volume lower than its 30 day average.

Mar 26, 2021 by Kwhen Finance Editors

PDS Biotechnology Corp. Shares Close the Week 21.6% Lower - Weekly Wrap
PDS Biotechnology Corp. shares closed this week 21.6% lower than it did at the end of last week. The stock is currently up 96.7% year-to-date, up 474.4% over the past 12 months, and down 39.6% over the past five years. This week, the Dow Jones Industrial Average rose 1.4%, and the S&P 500 rose 1.7%.

Trading Activity

  • Shares traded as high as $5.48 and as low as $4.00 this week.
  • Shares closed 4e+1% below its 52-week high and 6e+2% above its 52-week low.
  • Trading volume this week was 12.5% higher than the 10-day average and 77.3% lower than the 30-day average.
  • Beta, a measure of the stock’s volatility relative to the overall market stands at 1.5.

Technical Indicators

  • The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
  • MACD, a trend-following momentum indicator, indicates a downward trend.
  • The stock closed below its Bollinger band, indicating it may be oversold.

Market Comparative Performance

  • The company's share price lags the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis
  • The company's share price lags the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis
  • The company share price lags the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis
NameDoD %ΔYTD %Δ1 Yr %52-Week H %52-Week L %
PDS Biotechnology Corp.-5.496.7474.4-39.2621.6
Dow Jones Industrial Average1.48.649.8-1.461.3
S&P 500 Index1.66.354.0-1.562.9
Health Care1.93.038.0-3.841.1

Peer Group Comparative Performance

  • The company's stock price performance year-to-date beats the peer average by 113.6%
  • The company's stock price performance over the past 12 months beats the peer average by 334.3%
NameMKT CAP (USD)P/EYTD %Δ1 Yr %Δ52-Week H %52-Week L %
PDS Biotechnology Corp.PDSB096.7474.4-39.2621.6
Peer AvgN/A045.3109.2-26.3202.9
Ocular Therapeutix IncOCUL0-18.0247.7-24.7324.4
OncoCyte Corp.OCX098.3123.6-25.9323.5
Oragenics Inc.OGEN0100.865.6-54.5163.9

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.

Was this content valuable for you?

Tags: